ECOG-ACRIN EAY131-Z1M

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

New, Open

Phase 2 Study of Nivolumab and BMS-986016 (Relatlimab) in Patients with LAG-3+ Tumors with Mismatch Repair Deficiency (MMR-d) after Progression on Anti-PD-1/PD-L1 Therapy

(See required screening study ECOG-ACRIN EAY131)

NCT#02465060